Optiscan Imaging Limited
Optiscan Imaging Limited
Your view on OIL.AX
Overview
What the company does, where it operates, and who runs it.
About Optiscan Imaging Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Camile Farah
- Headquarters
- 16 Miles St, Mulgrave, VIC, AU
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Camile Farah
- Headquarters
- 16 Miles St, Mulgrave, VIC, AU
Optiscan Imaging Limited specializes in the development and market introduction of confocal microscopy technology, applied across both clinical and pre-clinical settings in Australia, Germany, and other global regions. A notable offering is the FIVE2 (ViewnVivo) system, a compact confocal endomicroscope utilized for a broad range of research, including clinical, translational, and pre-clinical studies. Additionally, the company is actively developing the InVivage device, which is intended for use in cancer screening and surgical procedures. Established in 1994, Optiscan Imaging Limited maintains its headquarters in Mulgrave, Australia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Optiscan Imaging Limited, and the rating behind it. OIL.AX last traded at AUD 0.17; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Optiscan Imaging Limited. Starting points for Optiscan Imaging Limited: EPS -AUD 0.0083, beta 0.10 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Optiscan Imaging Limited. Optiscan Imaging Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Optiscan Imaging Limited. Trailing twelve-month EPS for Optiscan Imaging Limited stands at -AUD 0.0083. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Optiscan Imaging Limited. Optiscan Imaging Limited has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Optiscan Imaging Limited valued side by side against its closest peers. Optiscan Imaging Limited is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Optiscan Imaging Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Optiscan Imaging Limited executives and directors. Shares of Optiscan Imaging Limited have traded between AUD 0.08 and AUD 0.17 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Optiscan Imaging Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Optiscan Imaging Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Optiscan Imaging Limited. Coverage tracks Optiscan Imaging Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.